Anika Therapeutics ANIK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Commercial Channel | $12.58M-5.5% | $13.3M+11.1% | $11.97M+0.8% | $11.88M+5.5% | $11.26M+3.0% | |
| OEM Channel | $17.04M-1.6% | $17.31M+9.3% | $15.84M-3.0% | $16.34M+9.6% | $14.91M-24.2% | |
| Revenue by Geography | ||||||
| Europe | $6.67M+11.2% | $6M+5.8% | $5.67M+19.3% | $4.75M-18.0% | $5.8M+33.9% | |
| Other Location | $4.41M-29.9% | $6.29M+33.8% | $4.7M-15.2% | $5.54M+38.3% | $4.01M-17.8% | |
| US | $18.53M+0.9% | $18.37M+5.3% | $17.45M-2.7% | $17.92M+9.3% | $16.4M-23.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
